Seidenberg Beth C

Seidenberg Beth C is listed in filings as Director at Kyverna Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including purchase activity and sale activity. Recent filings connect the profile to Kyverna Therapeutics, Inc. (KYTX), Vera Therapeutics, Inc. (VERA), Sagimet Biosciences Inc. (SGMT), and Acelyrin, Inc. (SLRN). The current snapshot covers public activity from Sep 20, 2024 to May 29, 2026. Reported amounts are shown as $176.8K to $1000.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.